Epigeneres Biotech - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2008, Epigeneres Biotech operates in Health Tech industry. Initially targeting personalized healthcare solutions, the company has since diversified its offerings to include innovative cance...
Funding stage:
Series B
Last funding:
21/01/2022
Total funding:
$12.00 Mn+
Investors
Web traffic:
1.57K
1.57K
Last 30d
Last 30d
Glassdoor Rating:
Epigeneres Biotech: Funding Highlights
Funding highlights of Epigeneres Biotech and a snapshot of its key metrics.
Total Funding$12.00 Mn+
Current StageGrowth Stage
Total Round(s)2
Funding Rounds
FAQs on Funding of Epigeneres Biotech
Health Tech Funded Epigeneres Biotech has raised a total funding of $12.00 million dollars as of 22 January 2022 across 2 rounds. Find the details around funding rounds, participating investors, and other insights of Epigeneres Biotech here...
Epigeneres Biotech has raised a total of $12.00 million dollars across 2 funding rounds and the last round was raised on 22 January 2022.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links